ISRCTN17943542已完成未知
The ADDFAM study: Realising the potential of the family history in risk assessment and primary prevention of Coronary Heart Disease (CHD) in primary care
niversity of Nottingham (UK)0 个研究点目标入组 1,400 人开始时间: 2007年10月8日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,400
研究概览
简要总结
- 2009 study protocol in http://www.ncbi.nlm.nih.gov/pubmed/19821989 2. 2012 results in http://www.ncbi.nlm.nih.gov/pubmed/22351711
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Practices: To be within either Trent Primary Care Trusts (PCTs) in East Midlands or PCTs in Central Cornwall, Plymouth and Exeter
- •Participants: To be registered patients at the above practices and be between 30 and 65 years of age; Practices: To be within either Trent Primary Care Trusts (PCTs) in East Midlands or PCTs in Central Cornwall, Plymouth and Exeter
- •Participants: To be registered patients at the above practices and be between 30 and 65 years of age
排除标准
- •General Practices outside of these defined areas will be excluded
- •Participants exclusion criteria:
- •1. Patients noted to have a previous history of atherosclerotic disease (this includes CHD, CerebroVascular Accident [CVA] and peripheral vascular disease)
- •2. Previous history of diabetes mellitus
- •3. Patients already on statin therapy or other lipid lowering medication
- •4. Patients considered by the General Practitioners to be inappropriate to recruit due to psychosocial reasons; General Practices outside of these defined areas will be excluded
- •Participants exclusion criteria:
- •1. Patients noted to have a previous history of atherosclerotic disease (this includes CHD, CerebroVascular Accident [CVA] and peripheral vascular disease)
- •2. Previous history of diabetes mellitus
- •3. Patients already on statin therapy or other lipid lowering medication
- •4. Patients considered by the General Practitioners to be inappropriate to recruit due to psychosocial reasons
研究者
相似试验
已完成
不适用
A feasibility study of an implementation strategy to improve the detection, assessment, management and prevention of delirium in hospicesISRCTN55416525niversity of Hull425
尚未招募
2 期
Phase II Study of Adebrelimab, Chemotherapy, and Apatinib for Advanced Pulmonary Neuroendocrine TumorsNeuroendocrine TumorsNCT06764368Beijing Chest Hospital39
已完成
2 期
A Study to Evaluate the Efficacy and Safety of AD-209Hypertension, EssentialNCT05631990Addpharma Inc.221
终止
3 期
DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract SurgeryMature CataractsNCT00596492Aqumen Biopharmaceuticals, N.A.200
已完成
不适用
Assessment of Disease Severity, Progression and Treatment in Infected Patients Presenting to the Emergency DepartmentSepsisNCT03992794Juan González-del Castillo684
